The goal of this consultation is to seek feedback on what Health Canada should consider in developing new clinical trials regulations as well as implementing the pathway for Advanced Therapeutic Products. The department aims to continue the conversation with stakeholders and gather other ideas to help ensure our approach supports innovation while protecting the health and safety of Canadians.
Send an email to hc.hpfb.engagement-
Health Canada wants to hear from consumers & patients, academia, industry, NGOs, medical professionals, and any other interested parties.
This consultation will close on August 30th, 2019.